Q-linea AB (publ) (QLINEA.ST)

SEK 0.97

(-1.62%)

Gross Profit Summary of Q-linea AB (publ)

  • Q-linea AB (publ)'s latest annual gross profit in 2023 was 995 Thousand SEK , down -981.63% from previous year.
  • Q-linea AB (publ)'s latest quarterly gross profit in 2024 Q2 was -65.35 Million SEK , down -14.32% from previous quarter.
  • Q-linea AB (publ) reported a annual gross profit of -21.38 Million SEK in annual gross profit 2022, up 14.58% from previous year.
  • Q-linea AB (publ) reported a annual gross profit of -25.02 Million SEK in annual gross profit 2021, up 21.83% from previous year.
  • Q-linea AB (publ) reported a quarterly gross profit of -65.35 Million SEK for 2024 Q2, down -14.32% from previous quarter.
  • Q-linea AB (publ) reported a quarterly gross profit of -2.13 Million SEK for 2023 Q2, down -181.69% from previous quarter.

Annual Gross Profit Chart of Q-linea AB (publ) (2023 - 2016)

Historical Annual Gross Profit of Q-linea AB (publ) (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 995 Thousand SEK -981.63%
2022 -21.38 Million SEK 14.58%
2021 -25.02 Million SEK 21.83%
2020 -32.02 Million SEK -14.96%
2019 -27.85 Million SEK -39.35%
2018 -19.98 Million SEK -119.41%
2017 -9.11 Million SEK -33.83%
2016 -6.8 Million SEK 0.0%

Peer Gross Profit Comparison of Q-linea AB (publ)

Name Gross Profit Gross Profit Difference
AddLife AB (publ) 2.77 Billion SEK 99.964%
Biotage AB (publ) 1.14 Billion SEK 99.913%
Bonesupport Holding AB (publ) 533.12 Million SEK 99.813%
Doxa AB (publ) 9.9 Million SEK 89.949%
Elekta AB (publ) 6.77 Billion SEK 99.985%
iZafe Group AB (publ) 293 Thousand SEK -239.59%
Ortivus AB (publ) 30.84 Million SEK 96.774%
Ortivus AB (publ) 30.84 Million SEK 96.774%
S2Medical AB (publ) 5.03 Million SEK 80.246%
Synsam AB (publ) 617 Million SEK 99.839%